Logo image of C

CITIGROUP INC (C) Stock Fundamental Analysis

NYSE:C - New York Stock Exchange, Inc. - US1729674242 - Common Stock - Currency: USD

80.63  +0.69 (+0.86%)

After market: 80.95 +0.32 (+0.4%)

Fundamental Rating

2

C gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 405 industry peers in the Banks industry. C has a bad profitability rating. Also its financial health evaluation is rather negative. C is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

C had positive earnings in the past year.
C had a negative operating cash flow in the past year.
Each year in the past 5 years C has been profitable.
The reported operating cash flow has been mixed in the past 5 years: C reported negative operating cash flow in multiple years.
C Yearly Net Income VS EBIT VS OCF VS FCFC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B -60B

1.2 Ratios

C has a Return On Assets of 0.28%. This is amonst the worse of the industry: C underperforms 84.17% of its industry peers.
With a Return On Equity value of 3.20%, C is not doing good in the industry: 84.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.28%
ROE 3.2%
ROIC N/A
ROA(3y)0.46%
ROA(5y)0.54%
ROE(3y)5.37%
ROE(5y)6.27%
ROIC(3y)N/A
ROIC(5y)N/A
C Yearly ROA, ROE, ROICC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With a Profit Margin value of 8.48%, C is not doing good in the industry: 86.43% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of C has declined.
The Operating Margin and Gross Margin are not available for C so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 8.48%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-21.21%
PM growth 5Y-10.41%
GM growth 3YN/A
GM growth 5YN/A
C Yearly Profit, Operating, Gross MarginsC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1

2. Health

2.1 Basic Checks

C does not have a ROIC to compare to the WACC, probably because it is not profitable.
C has less shares outstanding than it did 1 year ago.
C has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, C has a worse debt to assets ratio.
C Yearly Shares OutstandingC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
C Yearly Total Debt VS Total AssetsC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T 2T

2.2 Solvency

C has a Debt/Equity ratio of 2.89. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of C (2.89) is worse than 95.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.89
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC11.29%
C Yearly LT Debt VS Equity VS FCFC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
C Yearly Current Assets VS Current LiabilitesC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

4

3. Growth

3.1 Past

C shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.45%, which is quite good.
Measured over the past years, C shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.49% on average per year.
C shows a small growth in Revenue. In the last year, the Revenue has grown by 3.41%.
C shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)11.45%
EPS 3Y-14.19%
EPS 5Y-4.49%
EPS Q2Q%59.52%
Revenue 1Y (TTM)3.41%
Revenue growth 3Y4.12%
Revenue growth 5Y1.78%
Sales Q2Q%12.28%

3.2 Future

Based on estimates for the next years, C will show a small growth in Earnings Per Share. The EPS will grow by 5.73% on average per year.
The Revenue is expected to grow by 3.49% on average over the next years.
EPS Next Y18.68%
EPS Next 2Y21.61%
EPS Next 3Y4.65%
EPS Next 5Y5.73%
Revenue Next Year3.76%
Revenue Next 2Y3.71%
Revenue Next 3Y3.49%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
C Yearly Revenue VS EstimatesC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B
C Yearly EPS VS EstimatesC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.94, C is valued correctly.
C's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.28, C is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.91, the valuation of C can be described as very reasonable.
Based on the Price/Forward Earnings ratio, C is valued a bit cheaper than 65.58% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of C to the average of the S&P500 Index (91.29), we can say C is valued rather cheaply.
Industry RankSector Rank
PE 12.94
Fwd PE 10.91
C Price Earnings VS Forward Price EarningsC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
C Per share dataC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

C's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y21.61%
EPS Next 3Y4.65%

5

5. Dividend

5.1 Amount

C has a Yearly Dividend Yield of 2.73%.
Compared to an average industry Dividend Yield of 3.17, C has a dividend in line with its industry peers.
C's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.73%

5.2 History

The dividend of C has a limited annual growth rate of 5.95%.
C has paid a dividend for at least 10 years, which is a reliable track record.
C has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.95%
Div Incr Years2
Div Non Decr Years13
C Yearly Dividends per shareC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

77.62% of the earnings are spent on dividend by C. This is not a sustainable payout ratio.
The dividend of C is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP77.62%
EPS Next 2Y21.61%
EPS Next 3Y4.65%
C Yearly Income VS Free CF VS DividendC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B -60B
C Dividend Payout.C Dividend Payout, showing the Payout Ratio.C Dividend Payout.PayoutRetained Earnings

CITIGROUP INC

NYSE:C (1/29/2025, 8:08:17 PM)

After market: 80.95 +0.32 (+0.4%)

80.63

+0.69 (+0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-15 2025-01-15/bmo
Earnings (Next)N/A N/A
Inst Owners72.47%
Inst Owner Change0.51%
Ins Owners0.32%
Ins Owner Change-3.14%
Market Cap152.49B
Analysts80.71
Price Target82.43 (2.23%)
Short Float %1.99%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 2.73%
Yearly Dividend2.71
Dividend Growth(5Y)5.95%
DP77.62%
Div Incr Years2
Div Non Decr Years13
Ex-Date02-03 2025-02-03 (0.56)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.98%
Min EPS beat(2)7.18%
Max EPS beat(2)12.78%
EPS beat(4)4
Avg EPS beat(4)17.5%
Min EPS beat(4)2.01%
Max EPS beat(4)48.03%
EPS beat(8)7
Avg EPS beat(8)12.53%
EPS beat(12)11
Avg EPS beat(12)15.67%
EPS beat(16)15
Avg EPS beat(16)21.01%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.39%
Revenue beat(4)2
Avg Revenue beat(4)-2.15%
Min Revenue beat(4)-8.77%
Max Revenue beat(4)1.41%
Revenue beat(8)4
Avg Revenue beat(8)-0.46%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)10
Avg Revenue beat(16)0.81%
PT rev (1m)5.67%
PT rev (3m)10.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.76%
EPS NY rev (1m)0%
EPS NY rev (3m)1.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE 12.94
Fwd PE 10.91
P/S 1.93
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)6.23
EY7.73%
EPS(NY)7.39
Fwd EY9.17%
FCF(TTM)-29.46
FCFYN/A
OCF(TTM)-25.98
OCFYN/A
SpS41.77
BVpS110.55
TBVpS97.96
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.28%
ROE 3.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.48%
GM N/A
FCFM N/A
ROA(3y)0.46%
ROA(5y)0.54%
ROE(3y)5.37%
ROE(5y)6.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-21.21%
PM growth 5Y-10.41%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 147.33%
Cap/Sales 8.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.45%
EPS 3Y-14.19%
EPS 5Y-4.49%
EPS Q2Q%59.52%
EPS Next Y18.68%
EPS Next 2Y21.61%
EPS Next 3Y4.65%
EPS Next 5Y5.73%
Revenue 1Y (TTM)3.41%
Revenue growth 3Y4.12%
Revenue growth 5Y1.78%
Sales Q2Q%12.28%
Revenue Next Year3.76%
Revenue Next 2Y3.71%
Revenue Next 3Y3.49%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.17%
OCF growth 3YN/A
OCF growth 5YN/A